{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:40:45Z","timestamp":1772005245620,"version":"3.50.1"},"reference-count":21,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,12]]},"abstract":"<jats:p content-type=\"fine-print\"><jats:italic>Object.<\/jats:italic> It has been suggested that synchronous brain metastases (that is, those occurring within 2 months of primary cancer diagnosis) are associated with a shorter survival time compared with metachronous lesions (those occurring more than 2 months after primary cancer diagnosis). In this study the authors used data obtained from the National Cancer Institute's Surveillance, Epidemiology, and End Results program to determine the incidence of synchronous brain metastases and length of survival of patients in a defined population of southeastern Michigan residents.<\/jats:p><jats:p content-type=\"fine-print\"><jats:italic>Methods.<\/jats:italic> Data obtained in 2682 patients with synchronous brain metastases treated between 1973 and 1995 were reviewed. Study criteria included patients in whom at least one brain metastasis was diagnosed within 2 months of the diagnosis of primary cancer and those with an unknown primary source. The incidence per 100,000 population increased fivefold, from 0.69 in 1973 to 3.83 in 1995. The most frequent site for the primary cancer was the lung (75.4%). The second largest group (10.7%) consisted of patients in whom the primary site was unknown. The median length of survival was 3.2 months. There was no significant difference in the median survival of patients with primary lung\/bronchus and those with an unknown primary site (3.3 months and 3.2 months, respectively).<\/jats:p><jats:p content-type=\"fine-print\"><jats:italic>Conclusions.<\/jats:italic> Patients who present with synchronous lesions have a poor prognosis, and the predominant cause of death, in more than 90% of cases, is related to systemic disease; however, despite poor median survival times, certain patients will experience prolonged survival.<\/jats:p>","DOI":"10.3171\/jns.2000.93.6.0927","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:27:02Z","timestamp":1242235622000},"page":"927-931","source":"Crossref","is-referenced-by-count":33,"title":["Survival of patients with synchronous brain metastases: an epidemiological study in southeastern Michigan"],"prefix":"10.3171","volume":"93","author":[{"given":"Ajith J.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack P.","family":"Rock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Acta Neurochir","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/BF01420299","article-title":"Surgical resection of brain metastases from lung cancer.","volume":"138","author":"Andrews","year":"1996"},{"key":"b2","series-title":"Schweiz Arch Neurol Psychiatr","first-page":"179","article-title":"Considerations on the metastatic tumours of the brain with reference to statistics of 1217 cases.","volume":"117","author":"Arseni","year":"1975"},{"key":"b3","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0360-3016(96)85008-5","article-title":"A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.","volume":"35","author":"Auchter","year":"1996"},{"key":"b4","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00004424-198805000-00001","article-title":"Diagnostic imaging in clinical cancer management: brain metastases.","volume":"23","author":"Bentson","year":"1988"},{"key":"b5","series-title":"J Thorac Cardiovasc Surg","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0022-5223(19)34977-3","article-title":"Resection of brain metastases from non-small cell lung carcinoma. Results of therapy.","volume":"103","author":"Burt","year":"1992"},{"key":"b6","series-title":"Eur Neurol","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000117106","article-title":"Handling of single brain metastasis.","volume":"35","author":"Caplan","year":"1995"},{"key":"b7","series-title":"Br J Radiol","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1259\/0007-1285-63-753-712","article-title":"Comparison of spin echo T1-weighted and 90 degrees gadolinium-enhanced magnetic resonance imaging in the detection of cerebral metastases.","volume":"63","author":"Cherryman","year":"1990"},{"key":"b8","series-title":"Acta Neurol Scand","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-0404.1984.tb07791.x","article-title":"Epidemiology of central nervous system neoplasms. A regional survey in Central Finland.","volume":"69","author":"Fogelholm","year":"1984"},{"key":"b9","series-title":"Acta Neurol Scand","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1600-0404.1970.tb05811.x","article-title":"A survey of tumors of the central nervous system in Iceland during the 10-year period 1954\u20131963.","volume":"46","author":"Guomundsson","year":"1970"},{"key":"b10","series-title":"Nervenarzt","first-page":"104","article-title":"[Brain metastases as an initial manifestation of tumor disease.]","volume":"64","author":"Hamann","year":"1993"},{"key":"b11","series-title":"Neurosurg Clin North Am","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1042-3680(18)30365-6","article-title":"Demographics of brain metastases.","volume":"7","author":"Johnson","year":"1996"},{"key":"b12","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/1097-0142(19860801)58:3<641::AID-CNCR2820580308>3.0.CO;2-4","article-title":"The treatment of single brain metastasis from non-oat cell lung carcinoma.","volume":"58","author":"Mandell","year":"1986"},{"key":"b13","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/1097-0142(197802)41:2<776::AID-CNCR2820410253>3.0.CO;2-E","article-title":"Central nervous system involvement by ovarian carcinoma: a complication of prolonged survival with metastatic disease.","volume":"41","author":"Mayer","year":"1978"},{"key":"b14","series-title":"SEER Cancer Statistics Review: 1973\u20131990.","year":"1993"},{"key":"b15","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X","article-title":"A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.","volume":"78","author":"Mintz","year":"1996"},{"key":"b16","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/jnnp.57.8.950","article-title":"Surgical treatment of brain metastases of lung cancer: a retrospective analysis of 89 cases.","volume":"57","author":"Nakagawa","year":"1994"},{"key":"b17","series-title":"Prog Exp Tumor Res","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000411636","article-title":"Chemotherapy for brain metastases.","volume":"29","author":"Newlands","year":"1985"},{"key":"b18","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/1097-0142(19820215)49:4<651::AID-CNCR2820490408>3.0.CO;2-X","article-title":"Brain metastases in breast cancer patients receiving adjuvant chemotherapy.","volume":"49","author":"Paterson","year":"1982"},{"key":"b19","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/WNL.22.1.40","article-title":"Neoplasms of the central nervous system: epidemiologic considerations.","volume":"22","author":"Percy","year":"1972"},{"key":"b20","series-title":"Adv Neurol","first-page":"579","article-title":"Intracranial metastases from systemic cancer.","volume":"19","author":"Posner","year":"1978"},{"key":"b21","series-title":"CA Cancer J Clin","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.45.1.8","article-title":"Cancer statistics, 1995.","volume":"45","author":"Wingo","year":"1995"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/93\/6\/article-p927.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/93\/6\/article-p927.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/93\/6\/article-p927.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:44:30Z","timestamp":1679870670000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/93\/6\/article-p927.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":21,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/jns.2000.93.6.0927","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}